Nang Kuang Pharmaceutical Co., Ltd.

Taiwan Stock Exchange 1752.TW

Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 77.43 M

Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity is USD 77.43 M for the year ending December 31, 2023, a -1.55% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 78.65 M, a -2.68% change year over year.
Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 80.81 M, a 3.11% change year over year.
Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 78.38 M, a 7.19% change year over year.
Nang Kuang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 73.12 M, a 8.91% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Taiwan Stock Exchange: 1752.TW

Nang Kuang Pharmaceutical Co., Ltd.

CEO	Ms. Yu-Bei Wang
IPO Date	Jan. 20, 2022
Location	Taiwan
Headquarters	No. 1001, Zhongshan Road
Employees	552
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, anticancer injectable, injectable controlled and oral controlled products, and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years